Lung Cancer News

In this edition, reduction efforts prevent 3.8 million lung cancer deaths since 1970, first-line combination should be ‘new standard’ in advanced lung cancer and more.

Smoking status added to the National Cancer Database for patients diagnosed with cancer in 2023 revealed variations in sociodemographic and socioeconomic factors, according to a research letter in JAMA Oncology.

Cancer drugs that received accelerated approval from the FDA gained regular approval significantly faster if their confirmatory trials demonstrated meaningful clinical benefits, according to results of a retrospective study.

The number of Americans breathing unhealthy, polluted air where they lived between 2021 and 2023 totaled 156 million, which was a 25 million increase from last year’s State of the Air report, according to a press release.

Cancer mortality gradually declined over the past 2-plus decades, although the rate slowed between 2019 and 2022, according to results of the Annual Report to the Nation on the Status of Cancer.

A grassroots organization that formed with the goal of recalibrating cancer care around patient needs issued guidance intended to improve the design of randomized phase 3 trials.

A common malaria drug could be repurposed to treat a variety of hematologic cancers and solid tumors, according to early study results.

Jonathan Kimmelman, PhD, has published multiple research papers and gotten into an inordinate number of debates about the clinical value of phase 1 trials.

A text message-based electronic triage system showed efficacy for collecting patient-reported treatment outcomes and minimizing the time burden of cancer care, according to results of a pilot study.